Roche Media November 10, 2025
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed Fierce Biotech